Abstract
were significantly increased (p < 0.05) in the lamina propria of PI-IBS patients, while the number of CD19+ LPLs was decreased (p < 0.001) compared to healthy controls. Conclusion: We present new evidence that post-infectious irritable bowel syndrome (PI-IBS) is a disorder with a sustained aberrant mucosal immune response. These findings support future studies of anti-inflammatory or immune modulating treatments in PI-IBS patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
